GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Humanigen Inc (FRA:0KB2) » Definitions » Dividend-Payout-to-FFO

Humanigen (FRA:0KB2) Dividend-Payout-to-FFO


View and export this data going back to 2014. Start your Free Trial

What is Humanigen Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Humanigen (FRA:0KB2) Business Description

Traded in Other Exchanges
Address
830 Morris Turnpike, 4th Floor, Short Hills, NJ, USA, 07078
Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. It has one segment, which is related to the development of pharmaceutical products.